USHYETF

iShares Broad USD High Yield Corporate Bond ETF · CBOE

$35.80USD

↑ $0.14 (0.41%) Today

As of Oct 27, 11:59 AM ET · May be delayed

Sign up free to see this.

Daily prices
Volume
18.5M
52W High
$37.82
52W Low
$35.30
Avg Vol
17.1M
As of 10/26/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about USHY?

Latest news

News ›

Zacks Investment Research

Is Invesco Bloomberg Enhanced Fallen Angels ETF (IFLN) a Strong ETF Right Now?

The Invesco Bloomberg Enhanced Fallen Angels ETF (IFLN) is reviewed as a reasonable option for high-yield bond investors with a low expense ratio of 0.23% and 121 holdings. However, the ETF has declined 3.51% year-to-date and shows flat performance over the past year. Alternatives like HYG and USHY offer different risk-return profiles, with USHY featuring a lower expense ratio of 0.08%.

Zacks Investment Research

Is Invesco Global ex-US High Yield Corporate Bond ETF (PGHY) a Strong ETF Right Now?

The article reviews Invesco Global ex-US High Yield Corporate Bond ETF (PGHY), a smart beta ETF launched in 2013 with $226.87 million in assets. It offers a low expense ratio of 0.35% and a 7.30% dividend yield, but carries high risk with a standard deviation of 5.29%.

Zacks Investment Research

Is WisdomTree U.S. High Yield Corporate Bond ETF (QHY) a Strong ETF Right Now?

The article reviews WisdomTree U.S. High Yield Corporate Bond ETF (QHY), a smart beta ETF launched in 2016 with $243.62 million in assets. With a 0.38% expense ratio and 6.44% dividend yield, QHY tracks the WisdomTree US High Yield Corp Bond Index.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.